Polylysine dendrimer contrast agent

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9127130
APP PUB NO 20100278750A1
SERIAL NO

12377252

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to branched macromolecules and their use as imaging or contrast agents. In particular, the invention relates to dendrimers, derived from lysine or lysine analogs, bearing a plurality of functional moieties and their application to imaging techniques in which a disease state may be imaged with a targeted contrast agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAKER MEDICAL RESEARCH INSTITUTE75 COMMERCIAL ROAD VICTORIA MELBOURNE 3004
STARPHARMA PTY LTDBAKER BUILDING 75 COMMERCIAL ROAD PRAHAN VICTORIA 3004

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hagemeyer, Christoph Cheltenham, AU 3 12
Krippner, Guy Yeoman Newtown, AU 9 61
Owen, David Vermont South, AU 49 194
Peter, Karlheinz Hawthorn East, AU 36 108
Wu, Zemin Doncaster East, AU 9 46

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00